Purchases and Sales Made in Q1 2024 in Lyell Immunopharma, Inc. (LYEL)
This table provides information about the institutional ownership of Lyell Immunopharma, Inc. (LYEL) during Q1 2024. The information is specifically focused on institutions that hold shares of Lyell Immunopharma, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
May 15, 2024
Q1 2024
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-202K- 32.18% |
$345K - $620K
|
426K
$468K
|
|
|
May 10, 2024
Q1 2024
|
Vanguard Group Inc
Valley Forge, PA |
SELL
|
- |
-216K- 1.58% |
$369K - $662K
|
13.4M
$14.7M
|
|
|
May 15, 2024
Q1 2024
|
Squarepoint Ops LLC
New York, NY |
SELL
|
- |
-231K- 75.82% |
$395K - $709K
|
73.7K
$81.1K
|
|
|
May 10, 2024
Q1 2024
|
Black Rock Inc.
New York, NY |
SELL
|
- |
-410K- 2.86% |
$700K - $1.26M
|
13.9M
$15.3M
|
|
|
May 15, 2024
Q1 2024
|
Bank Of America Corp
Charlotte, NC |
SELL
|
- |
-1.44M- 86.78% |
$2.46M - $4.42M
|
219K
$241K
|
|
|
May 15, 2024
Q1 2024
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-2.69M- 77.39% |
$4.6M - $8.26M
|
786K
$865K
|